Takeda Pharmaceutical Company's total assets for Q3 2025 were ¥15.42T, an increase of 6.56% from the previous quarter. TAK total liabilities were ¥7.77T for the fiscal quarter, a 5.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.